相关实验视频
Updated: Jun 26, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
自动化胰岛素输送技术在糖尿病中的作用
Charlotte K Boughton1, Roman Hovorka2
1Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK. cb2000@medschl.cam.ac.uk.
Diabetologia
|May 13, 2024
概括
混合闭环系统越来越多地用于1型糖尿病管理,现实数据证实了它们的有效性. 本综述涵盖了当前的系统,新兴的用途以及自动化胰岛素输送的未来改进.
科学领域:
- 内分泌学和新陈代谢学
- 生物医学工程 生物医学工程
- 糖尿病 技术 技术
背景情况:
- 自动化胰岛素输送 (AID) 系统,特别是混合闭环 (HCL) 系统,正在成为糖尿病护理的组成部分.
- 现实世界的数据越来越多地支持在临床试验中证明的HCL系统的有效性和可用性.
研究的目的:
- 审查目前可用的商业HCL系统及其特点.
- 分析关于HCL系统性能和可用性的现实数据.
- 探索糖尿病管理中AID技术的新兴应用和未来方向.
主要方法:
- 商业上可用的混合闭环胰岛素输送系统的审查.
- 分析公布的关于系统性能和患者报告的结果的真实数据.
- 讨论AID技术当前的挑战和未来的创新.
主要成果:
- 现实世界的数据验证了HCL系统在1型糖尿病管理中的性能和可用性.
- HCL系统在2型糖尿病和其他具有高胰岛素变异性的复杂病例中表现有前途.
- 确定了实施挑战和系统局限性,以及正在进行的性能提升研究.
结论:
- 混合闭环系统是当代糖尿病管理中的一个有价值的工具,现实应用中的证据越来越多.
- 未来的研究应该专注于扩大指示,提高系统性能,解决访问和实施障碍.
- 持续在自动化胰岛素输送方面的创新对于优化不同患者群体的糖尿病护理至关重要.
相关概念视频
Insulin Formulations: Types and Delivery
191
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
191
Insulin: Dosing Regimen and Adverse Effects
167
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
167
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
266
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
266
Insulin: Biosynthesis, Chemistry, and Preparation
374
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
374
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K

